Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | HIKAL Hikal Limited Pharma · Small | AARTIPHARM Aarti Pharmalabs Limited Pharma · Micro | COHANCE Cohance Lifesciences Limited Pharma · Small | SYNGENE Syngene International Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 33 | 35 | 30 | 29 |
| Verdict | WATCHLIST | WATCHLIST | OVERVALUED | OVERVALUED |
| Style | WATCHLIST | WATCHLIST | OVERVALUED | OVERVALUED |
| Piotroski | 7/9 | 8/9 | 7/9 | 8/9 |
| Valuation | 5/30 | 7/30 | 1/30 | 2/30 |
| Growth | 4/25 | 12/25 | 7/25 | 7/25 |
| Quality | 0/20 | 0/20 | 0/20 | 0/20 |
| Balance Sheet | 9/15 | 8/15 | 10/15 | 11/15 |
| Cash Flow | 9/10 | 2/10 | 6/10 | 4/10 |
| Price | ₹181.69 | ₹625.25 | ₹432.4 | ₹444.3 |
| P/E | 61.10 | 31.10 | 82.30 | 48.30 |
| P/B | 1.85 | 2.59 | 4.16 | 3.75 |
| ROE | 2.95% | 8.59% | 7.04% | 7.86% |
| ROCE | 3.52% | 10.70% | 8.35% | 10.10% |
| Debt / Equity | 0.57 | 0.43 | 0.10 | 0.09 |
| FCF Yield | 7.08% | — | 0.70% | 0.30% |
| Dividend Y | 0.78% | 0.82% | — | 0.28% |
| Altman Z | 3.05 | 3.65 | 7.19 | 7.00 |
| Promoter % | 68.85% | 43.08% | 57.49% | 52.68% |
| Mkt Cap (₹Cr) | 2217.00 | 5497.00 | 16238.00 | 18147.00 |
| Graham # | — | ₹318.52 | ₹103.64 | ₹145.68 |
| Fair PE | 2.2 | 42.0 | 3.8 | 8.3 |
| MoS % | -2728.7% | +22.7% | -2350.7% | -581.9% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startHIKAL47
AARTIPHARM95
COHANCE40
SYNGENE49